Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Sgouros

Showing results (61-70 of 69) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 69 results.
Cancer|December 24, 1997
Single chain antigen binding protein (sFv CC49): first human studies in colorectal carcinoma metastatic to liverS M Larson, A M El-Shirbiny, C R Divgi, et al.
Cancer|December 24, 1997
Overcoming the nephrotoxicity of radiometal-labeled immunoconjugates: improved cancer therapy administered to a nude mouse model in relation to the internal radiation dosimetryT M Behr, R M Sharkey, G Sgouros, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 24, 1999
Pharmacokinetics and dosimetry of an alpha-particle emitter labeled antibody: 213Bi-HuM195 (anti-CD33) in patients with leukemiaG Sgouros, A M Ballangrud, J G Jurcic, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 30, 1999
Studies on the red marrow dosimetry in radioimmunotherapy: an experimental investigation of factors influencing the radiation-induced myelotoxicity in therapy with beta-, Auger/conversion electron-, or alpha-emittersT M Behr, G Sgouros, M G Stabin, et al.
Bone Marrow Transplantation|September 4, 2003
Cytoreduction with iodine-131-anti-CD33 antibodies before bone marrow transplantation for advanced myeloid leukemiasJ M Burke, P C Caron, E B Papadopoulos, et al.
Physics in Medicine and Biology|November 9, 2013
Use of the FLUKA Monte Carlo code for 3D patient-specific dosimetry on PET-CT and SPECT-CT imagesF Botta, A Mairani, R F Hobbs, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 1998
Interferon-gamma and monoclonal antibody 131I-labeled CC49: outcomes in patients with androgen-independent prostate cancerS F Slovin, H I Scher, C R Divgi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 26, 1998
Phase I/II radioimmunotherapy trial with iodine-131-labeled monoclonal antibody G250 in metastatic renal cell carcinomaC R Divgi, N H Bander, A M Scott, et al.
Cancer Research|November 21, 2000
An alpha-particle emitting antibody ([213Bi]J591) for radioimmunotherapy of prostate cancerM R McDevitt, E Barendswaard, D Ma, et al.
Pageof 7

Showing results (61-70 of 69) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 69 results.
Cancer|December 24, 1997
Single chain antigen binding protein (sFv CC49): first human studies in colorectal carcinoma metastatic to liverS M Larson, A M El-Shirbiny, C R Divgi, et al.
Cancer|December 24, 1997
Overcoming the nephrotoxicity of radiometal-labeled immunoconjugates: improved cancer therapy administered to a nude mouse model in relation to the internal radiation dosimetryT M Behr, R M Sharkey, G Sgouros, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 24, 1999
Pharmacokinetics and dosimetry of an alpha-particle emitter labeled antibody: 213Bi-HuM195 (anti-CD33) in patients with leukemiaG Sgouros, A M Ballangrud, J G Jurcic, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 30, 1999
Studies on the red marrow dosimetry in radioimmunotherapy: an experimental investigation of factors influencing the radiation-induced myelotoxicity in therapy with beta-, Auger/conversion electron-, or alpha-emittersT M Behr, G Sgouros, M G Stabin, et al.
Bone Marrow Transplantation|September 4, 2003
Cytoreduction with iodine-131-anti-CD33 antibodies before bone marrow transplantation for advanced myeloid leukemiasJ M Burke, P C Caron, E B Papadopoulos, et al.
Physics in Medicine and Biology|November 9, 2013
Use of the FLUKA Monte Carlo code for 3D patient-specific dosimetry on PET-CT and SPECT-CT imagesF Botta, A Mairani, R F Hobbs, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 1998
Interferon-gamma and monoclonal antibody 131I-labeled CC49: outcomes in patients with androgen-independent prostate cancerS F Slovin, H I Scher, C R Divgi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 26, 1998
Phase I/II radioimmunotherapy trial with iodine-131-labeled monoclonal antibody G250 in metastatic renal cell carcinomaC R Divgi, N H Bander, A M Scott, et al.
Cancer Research|November 21, 2000
An alpha-particle emitting antibody ([213Bi]J591) for radioimmunotherapy of prostate cancerM R McDevitt, E Barendswaard, D Ma, et al.
Pageof 7